Laya Ekhlaspour, MD

Title(s)Assistant Professor, Pediatrics
SchoolSchool of Medicine
Address1550 Fourth Street, #001
San Francisco CA 94158
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0002-3263-1419 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Kerman University of Medical Sciences, Kerman, IranMD.02/2006Doctor of Medicine
    Icahn School of Medicine at Mount Sinai ( Elmhurst Medical Center), New York06/2012Pediatric Residency Training
    Harvard School of Medicine (Massachusetts General Hospital for Children), Boston, MA072016Pediatric Endocrinology Fellowship
    University of California, San Francisco, San Francisco2022Diversity, Equity, and Inclusion Championship Training

    Collapse Overview 
    Collapse Overview
    I am a physician-scientist and an assistant Professor of Pediatrics at the University of California, San Francisco, and my research is focused on the use of technology in children with type 1 diabetes. Since my training, I have focused on testing and developing novel diabetes technologies, including continuous glucose monitors and automated insulin delivery systems and have been a co-investigator on multiple NIH, JDRF, and industry-funded studies. I have received an NIH grant to address the impact of meal composition on postprandial glucose excursions in closed-loop systems.
    Collapse Mentoring

    Collapse Research 
    Collapse Research Activities and Funding
    Modeling and modulating insulin delivery in automated insulin delivery systems to accommodate for meal compositions
    NIH K23DK121942Jul 1, 2020 - Apr 30, 2025
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. ISPAD Clinical Practice Consensus Guidelines 2024: Diabetes Technologies: Insulin Delivery. Horm Res Paediatr. 2024 Dec 10; 1-34. Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard ME, Reddy L, Sap Ngo Um S, Schoelwer M, Sherr JL, Dovc K. PMID: 39657603.
      View in: PubMed   Mentions:
    2. Discordance Between Clinician and Person-With-Diabetes Perceptions Regarding Technology Barriers and Benefits. J Diabetes Sci Technol. 2024 Oct 06; 19322968241285045. Addala A, Howard KR, Hosseinipour Y, Ekhlaspour L. PMID: 39369311.
      View in: PubMed   Mentions:    Fields:    
    3. Time to Moderate and Severe Hyperglycemia and Ketonemia Following an Insulin Pump Occlusion. J Diabetes Sci Technol. 2024 Nov; 18(6):1472-1479. Klonoff DC, Ayers AT, Ho CN, Fabris C, Villa-Tamayo MF, Allen E, Cengiz E, Ekhlaspour L, Wong JC, Heineman L, Kohn MA. PMID: 39240028; PMCID: PMC11531023.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study. Diabetes Technol Ther. 2024 Jun 24. Laugesen C, Ritschel T, Ranjan AG, Hsu L, Jørgensen JB, Svensson J, Ekhlaspour L, Buckingham B, Nørgaard K. PMID: 38805311.
      View in: PubMed   Mentions:    Fields:    
    5. Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience. J Clin Transl Endocrinol. 2024 Jun; 36:100352. Ekhlaspour L, Buckingham B, Bauza C, Clements M, Forlenza GP, Neyman A, Norlander L, Schamberger M, Sherr JL, Bailey R, Beck RW, Kollman C, Beasley S, Cobry E, DiMeglio LA, Paprocki E, Van Name M, Moran A, CLVer Study Group. PMID: 38860154; PMCID: PMC11163172.
      View in: PubMed   Mentions: 1  
    6. Corrigendum to "New therapies towards a better glycemic control in youths with type 1 diabetes" [Pharmacol. Res. 2023 Aug 3;195:106882]. Pharmacol Res. 2024 Apr; 202:107109. Cardona-Hernandez R, Dôvc K, Biester T, Ekhlaspour L, Macedoni M, Tauschmann M, Mameli C. PMID: 38413347; PMCID: PMC11094625.
      View in: PubMed   Mentions:    Fields:    
    7. The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions. IEEE Trans Biomed Eng. 2024 Mar; 71(3):977-986. Faggionato E, Schiavon M, Ekhlaspour L, Buckingham BA, Dalla Man C. PMID: 37844003; PMCID: PMC10973685.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology. Diabetes Res Clin Pract. 2024 Feb; 208:111114. Hood KK, Schneider-Utaka AK, Reed ZW, Buckingham BA, Cobry E, DeBoer MD, Ekhlaspour L, Schoelwer M, Paul Wadwa R, Lum J, Kollman C, Beck RW, Breton MD, PEDAP Trial Study Group. PMID: 38278493; PMCID: PMC10972785.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. New therapies towards a better glycemic control in youths with type 1 diabetes. Pharmacol Res. 2023 09; 195:106882. Cardona-Hernandez R, Dôvc K, Biester T, Ekhlaspour L, Macedoni M, Tauschmann M, Mameli C. PMID: 37543096; PMCID: PMC11073821.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2023 03 28; 329(12):980-989. McVean J, Forlenza GP, Beck RW, Bauza C, Bailey R, Buckingham B, DiMeglio LA, Sherr JL, Clements M, Neyman A, Evans-Molina C, Sims EK, Messer LH, Ekhlaspour L, McDonough R, Van Name M, Rojas D, Beasley S, DuBose S, Kollman C, Moran A, CLVer Study Group. PMID: 36826834; PMCID: PMC9960023.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    11. Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2023 03 28; 329(12):990-999. Forlenza GP, McVean J, Beck RW, Bauza C, Bailey R, Buckingham B, DiMeglio LA, Sherr JL, Clements M, Neyman A, Evans-Molina C, Sims EK, Messer LH, Ekhlaspour L, McDonough R, Van Name M, Rojas D, Beasley S, DuBose S, Kollman C, Moran A, CLVer Study Group. PMID: 36826844; PMCID: PMC9960020.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    12. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. N Engl J Med. 2023 Mar 16; 388(11):991-1001. Wadwa RP, Reed ZW, Buckingham BA, DeBoer MD, Ekhlaspour L, Forlenza GP, Schoelwer M, Lum J, Kollman C, Beck RW, Breton MD, PEDAP Trial Study Group. PMID: 36920756; PMCID: PMC10082994.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    13. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocr Rev. 2023 03 04; 44(2):254-280. Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O'Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. PMID: 36066457; PMCID: PMC9985411.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    14. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 09 29; 387(13):1161-1172. Bionic Pancreas Research Group, Russell SJ, Beck RW, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Calhoun P, Wadwa RP, Buckingham B, Zhou K, Daniels M, Raskin P, White PC, Lynch J, Pettus J, Hirsch IB, Goland R, Buse JB, Kruger D, Mauras N, Muir A, McGill JB, Cogen F, Weissberg-Benchell J, Sherwood JS, Castellanos LE, Hillard MA, Tuffaha M, Putman MS, Sands MY, Forlenza G, Slover R, Messer LH, Cobry E, Shah VN, Polsky S, Lal R, Ekhlaspour L, Hughes MS, Basina M, Hatipoglu B, Olansky L, Bhangoo A, Forghani N, Kashmiri H, Sutton F, Choudhary A, Penn J, Jafri R, Rayas M, Escaname E, Kerr C, Favela-Prezas R, Boeder S, Trikudanathan S, Williams KM, Leibel N, Kirkman MS, Bergamo K, Klein KR, Dostou JM, Machineni S, Young LA, Diner JC, Bhan A, Jones JK, Benson M, Bird K, Englert K, Permuy J, Cossen K, Felner E, Salam M, Silverstein JM, Adamson S, Cedeno A, Meighan S, Dauber A. PMID: 36170500; PMCID: PMC10028490.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    15. Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care. 2022 08 01; 45(8):1907-1910. Sherr JL, Bode BW, Forlenza GP, Laffel LM, Schoelwer MJ, Buckingham BA, Criego AB, DeSalvo DJ, MacLeish SA, Hansen DW, Ly TT, Omnipod 5 in Preschoolers Study Group:, Sherr JL, Weyman K, Tichy E, VanName M, Brei M, Zgorski M, Steffen A, Carria L, Bode BW, Busby A, Forlenza GP, Wadwa RP, Slover R, Cobry E, Messer L, Laffel LM, Isganaitis E, Ambler-Osborn L, Freiner E, Turcotte C, Volkening L, Schoelwer M, Brown SA, Krauthause K, Emory E, Oliveri M, Buckingham BA, Ekhlaspour L, Kingman R, Criego AB, Schwartz BL, Gandrud LM, Grieme A, Hyatt J, DeSalvo DJ, McKay S, DeLaO K, Villegas C, MacLeish SA, Wood JR, Kaminski BA, Casey T, Campbell W, Behm K, Adams R, Hansen DW, Stone SL, Bzdick S, Bulger J, Agostini L, Doolittle S, Kivilaid K, Kleve K, Ly TT, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E. PMID: 35678724; PMCID: PMC9346983.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    16. Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4. Diabetes Technol Ther. 2022 09; 24(9):635-642. Pinsker JE, Dassau E, Deshpande S, Raghinaru D, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Church MM, Desrochers H, Ekhlaspour L, Kaur RJ, Levister C, Shi D, Lum JW, Kollman C, Doyle FJ, iDCL Trial Research Group. PMID: 35549708; PMCID: PMC9422791.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial. J Diabetes Sci Technol. 2023 Jul; 17(4):935-942. Ekhlaspour L, Raghinaru D, Forlenza GP, Isganaitis E, Kudva YC, Lam DW, Levister C, O'Malley G, Church MM, Lum JW, Buckingham B, Brown SA. PMID: 35473359; PMCID: PMC10347978.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health. 2022 04; 4(4):e245-e255. Ware J, Boughton CK, Allen JM, Wilinska ME, Tauschmann M, Denvir L, Thankamony A, Campbell FM, Wadwa RP, Buckingham BA, Davis N, DiMeglio LA, Mauras N, Besser REJ, Ghatak A, Weinzimer SA, Hood KK, Fox DS, Kanapka L, Kollman C, Sibayan J, Beck RW, Hovorka R, DAN05 Consortium. PMID: 35272971.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    19. Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2022 08; 24(8):588-591. Ekhlaspour L, Town M, Raghinaru D, Lum JW, Brown SA, Buckingham BA. PMID: 35020488; PMCID: PMC9353995.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial. Pediatr Diabetes. 2022 05; 23(3):324-329. Forlenza GP, Ekhlaspour L, DiMeglio LA, Fox LA, Rodriguez H, Shulman DI, Kaiserman KB, Liljenquist DR, Shin J, Lee SW, Buckingham BA. PMID: 35001477; PMCID: PMC9304187.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    21. Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study. Diabetes Care. 2022 01 01; 45(1):186-193. Bisio A, Anderson S, Norlander L, O'Malley G, Robic J, Ogyaadu S, Hsu L, Levister C, Ekhlaspour L, Lam DW, Levy C, Buckingham B, Breton MD. PMID: 34794973; PMCID: PMC8753765.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2021 10; 23(10):673-683. Kudva YC, Laffel LM, Brown SA, Raghinaru D, Pinsker JE, Ekhlaspour L, Levy CJ, Messer LH, Kovatchev BP, Lum JW, Beck RW, Gonder-Frederick L, iDCL Trial Research Group. PMID: 34115959; PMCID: PMC8573794.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    23. Adjunctive Therapies to Optimize Closed-loop Glucose Control. J Diabetes Sci Technol. 2021 11; 15(6):1243-1251. Srinivasan S, Ekhlaspour L, Cengiz E. PMID: 34315267; PMCID: PMC8655279.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care. 2021 07; 44(7):1630-1640. Brown SA, Forlenza GP, Bode BW, Pinsker JE, Levy CJ, Criego AB, Hansen DW, Hirsch IB, Carlson AL, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, Weinstock RS, MacLeish SA, DeSalvo DJ, Jones TC, Aleppo G, Buckingham BA, Ly TT, Omnipod 5 Research Group. PMID: 34099518; PMCID: PMC8323171.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    25. Diabetes Technology and Therapy in the Pediatric Age Group. Diabetes Technol Ther. 2021 06; 23(S2):S113-S130. Maahs DM, Ekhlaspour L, Shalitin S. PMID: 34061625; PMCID: PMC8881949.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial. Diabetes Technol Ther. 2021 04; 23(4):245-252. O'Malley G, Messer LH, Levy CJ, Pinsker JE, Forlenza GP, Isganaitis E, Kudva YC, Ekhlaspour L, Raghinaru D, Lum J, Brown SA, iDCL Trial Research Group. PMID: 33155824; PMCID: PMC8114941.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technol Ther. 2021 07; 23(7):475-481. Schoelwer MJ, Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cobry EC, Messer LH, Cengiz E, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, Buckingham BA, Lal RA, Oliveri MC, Kollman CC, Dokken BB, Cherñavvsky DR, Beck RW, DeBoer MD, iDCL Trial Research Group. PMID: 33689454; PMCID: PMC8252894.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technol Ther. 2021 06; 23(6):401-409. Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, Hood KK, Hsu LJ, Messer LH, Schoelwer MJ, Emory E, Ruedy KJ, Beck RW, Wadwa RP, Gonder-Frederick L, iDCL Trial Research Group. PMID: 33404325; PMCID: PMC8215424.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    29. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2021 05; 23(5):342-349. Isganaitis E, Raghinaru D, Ambler-Osborn L, Pinsker JE, Buckingham BA, Wadwa RP, Ekhlaspour L, Kudva YC, Levy CJ, Forlenza GP, Beck RW, Kollman C, Lum JW, Brown SA, Laffel LM, iDCL Trial Research Group. PMID: 33216667; PMCID: PMC8080922.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    30. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 06; 23(6):410-424. Forlenza GP, Buckingham BA, Brown SA, Bode BW, Levy CJ, Criego AB, Wadwa RP, Cobry EC, Slover RJ, Messer LH, Berget C, McCoy S, Ekhlaspour L, Kingman RS, Voelmle MK, Boyd J, O'Malley G, Grieme A, Kivilaid K, Kleve K, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E, Ly TT. PMID: 33325779; PMCID: PMC8215410.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    31. Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System. Diabetes Technol Ther. 2021 01; 23(1):1-7. Hsu L, Buckingham B, Basina M, Ekhlaspour L, von Eyben R, Wang J, Lal RA. PMID: 32520594; PMCID: PMC7864093.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    32. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes. Diabetes Care. 2021 02; 44(2):473-478. Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer MJ, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, DeBoer MD, Buckingham BA, Oliveri M, Kollman C, Dokken BB, Cherñavvsky D, Beck RW, iDCL Trial Research Group. PMID: 33355258; PMCID: PMC7818334.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    33. Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers. Diabetes Technol Ther. 2021 05; 23(5):384-391. Ekhlaspour L, Schoelwer MJ, Forlenza GP, DeBoer MD, Norlander L, Hsu L, Kingman R, Boranian E, Berget C, Emory E, Buckingham BA, Breton MD, Wadwa RP. PMID: 33226837; PMCID: PMC8080923.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    34. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. N Engl J Med. 2020 08 27; 383(9):836-845. Breton MD, Kanapka LG, Beck RW, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer M, Ruedy KJ, Jost E, Carria L, Emory E, Hsu LJ, Oliveri M, Kollman CC, Dokken BB, Weinzimer SA, DeBoer MD, Buckingham BA, Cherñavvsky D, Wadwa RP, iDCL Trial Research Group. PMID: 32846062; PMCID: PMC7920146.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    35. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2020 08; 43(8):1822-1828. Brown SA, Beck RW, Raghinaru D, Buckingham BA, Laffel LM, Wadwa RP, Kudva YC, Levy CJ, Pinsker JE, Dassau E, Doyle FJ, Ambler-Osborn L, Anderson SM, Church MM, Ekhlaspour L, Forlenza GP, Levister C, Simha V, Breton MD, Kollman C, Lum JW, Kovatchev BP, iDCL Trial Research Group. PMID: 32471910; PMCID: PMC7372060.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    36. Erratum. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care 2020;43:607-615. Diabetes Care. 2020 Jun; 43(6):1366. Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW, iDCL Study Group. PMID: 32245747; PMCID: PMC7245358.
      View in: PubMed   Mentions:    Fields:    
    37. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care. 2020 03; 43(3):607-615. Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW, iDCL Study Group. PMID: 31937608; PMCID: PMC7035585.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    38. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes. Endocr Rev. 2019 12 01; 40(6):1521-1546. Lal RA, Ekhlaspour L, Hood K, Buckingham B. PMID: 31276160; PMCID: PMC6821212.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    39. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technol Ther. 2020 03; 22(3):174-184. Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu L, Berget C, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT. PMID: 31596130; PMCID: PMC7047109.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    40. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019 10 31; 381(18):1707-1717. Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW, iDCL Trial Research Group. PMID: 31618560; PMCID: PMC7076915.
      View in: PubMed   Mentions: 330     Fields:    Translation:Humans
    41. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. J Diabetes Sci Technol. 2019 11; 13(6):1001-1007. Ekhlaspour L, Nally LM, El-Khatib FH, Ly TT, Clinton P, Frank E, Tanenbaum ML, Hanes SJ, Selagamsetty RR, Hood K, Damiano ER, Buckingham BA. PMID: 31470740; PMCID: PMC6835195.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    42. Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults. JCI Insight. 2019 06 18; 5. Williams VJ, Trombetta BA, Jafri RZ, Koenig AM, Wennick CD, Carlyle BC, Ekhlaspour L, Ahima RS, Russell SJ, Salat DH, Arnold SE. PMID: 31211691; PMCID: PMC6675560.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery. J Diabetes Sci Technol. 2019 07; 13(4):645-663. Ekhlaspour L, Tabatabai I, Buckingham B. PMID: 31130007; PMCID: PMC6610610.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system. Pediatr Diabetes. 2019 09; 20(6):759-768. Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, Messer LH, Town M, Pinnata J, Kruse G, Kovatchev BP, Buckingham BA, Breton MD. PMID: 31099946; PMCID: PMC6679803.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    45. Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial. Diabetes Technol Ther. 2019 04; 21(4):159-169. Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D. PMID: 30888835; PMCID: PMC6909715.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    46. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Diabetes Care. 2018 10; 41(10):2155-2161. Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, Wadwa RP, Ekhlaspour L, Church MM, Weinzimer SA, Jost E, Marcal T, Andre C, Carria L, Swanson V, Lum JW, Kollman C, Woodall W, Beck RW. PMID: 30089663.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    47. Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents. Pediatr Diabetes. 2018 05; 19(3):420-428. Forlenza GP, Raghinaru D, Cameron F, Wayne Bequette B, Peter Chase H, Paul Wadwa R, Maahs DM, Jost E, Ly TT, Wilson DM, Norlander L, Ekhlaspour L, Min H, Clinton P, Njeru N, Lum JW, Kollman C, Beck RW, Buckingham BA, In-Home Closed-Loop (IHCL) Study Group. PMID: 29159870; PMCID: PMC5951790.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    48. Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next Steps. Curr Diab Rep. 2017 08; 17(8):58. Driscoll KA, Corbin KD, Maahs DM, Pratley R, Bishop FK, Kahkoska A, Hood KK, Mayer-Davis E, Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON). PMID: 28660565; PMCID: PMC6053070.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    49. In-Home Closed Loop Control for Artificial Pancreas: Patient and Provider Perspective. Diabetes Technol Ther. 2017 01; 19(1):4-6. Ekhlaspour L, Maahs DM. PMID: 28055224; PMCID: PMC6435341.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet. 2017 01 28; 389(10067):369-380. El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ. PMID: 28007348; PMCID: PMC5358809.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    51. Bone Density in Adolescents and Young Adults with Autism Spectrum Disorders. J Autism Dev Disord. 2016 Nov; 46(11):3387-3391. Ekhlaspour L, Baskaran C, Campoverde KJ, Sokoloff NC, Neumeyer AM, Misra M. PMID: 27491424; PMCID: PMC5074906.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    52. Comparative Accuracy of 17 Point-of-Care Glucose Meters. J Diabetes Sci Technol. 2017 05; 11(3):558-566. Ekhlaspour L, Mondesir D, Lautsch N, Balliro C, Hillard M, Magyar K, Radocchia LG, Esmaeili A, Sinha M, Russell SJ. PMID: 27697848; PMCID: PMC5505415.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    53. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol. 2016 Mar; 4(3):233-243. Russell SJ, Hillard MA, Balliro C, Magyar KL, Selagamsetty R, Sinha M, Grennan K, Mondesir D, Ekhlaspour L, Zheng H, Damiano ER, El-Khatib FH. PMID: 26850709; PMCID: PMC4799495.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCTClinical Trials
    Laya's Networks
    Concepts (99)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.